X-133953183-C-T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_004484.4(GPC3):​c.204G>A​(p.Lys68Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00201 in 1,207,011 control chromosomes in the GnomAD database, including 31 homozygotes. There are 597 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.011 ( 22 hom., 289 hem., cov: 23)
Exomes 𝑓: 0.0011 ( 9 hom. 308 hem. )

Consequence

GPC3
NM_004484.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 1.91

Publications

2 publications found
Variant links:
Genes affected
GPC3 (HGNC:4451): (glypican 3) Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage. These proteins may play a role in the control of cell division and growth regulation. The protein encoded by this gene can bind to and inhibit the dipeptidyl peptidase activity of CD26, and it can induce apoptosis in certain cell types. Deletion mutations in this gene are associated with Simpson-Golabi-Behmel syndrome, also known as Simpson dysmorphia syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
GPC3 Gene-Disease associations (from GenCC):
  • Simpson-Golabi-Behmel syndrome
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Simpson-Golabi-Behmel syndrome type 1
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.37).
BP6
Variant X-133953183-C-T is Benign according to our data. Variant chrX-133953183-C-T is described in ClinVar as Benign. ClinVar VariationId is 415272.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.91 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0108 (1191/110530) while in subpopulation AFR AF = 0.0363 (1103/30350). AF 95% confidence interval is 0.0346. There are 22 homozygotes in GnomAd4. There are 289 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 22 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004484.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GPC3
NM_004484.4
MANE Select
c.204G>Ap.Lys68Lys
synonymous
Exon 2 of 8NP_004475.1I6QTG3
GPC3
NM_001164617.2
c.204G>Ap.Lys68Lys
synonymous
Exon 2 of 9NP_001158089.1P51654-3
GPC3
NM_001164618.2
c.204G>Ap.Lys68Lys
synonymous
Exon 2 of 8NP_001158090.1B4DTD8

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GPC3
ENST00000370818.8
TSL:1 MANE Select
c.204G>Ap.Lys68Lys
synonymous
Exon 2 of 8ENSP00000359854.3P51654-1
GPC3
ENST00000394299.7
TSL:1
c.204G>Ap.Lys68Lys
synonymous
Exon 2 of 9ENSP00000377836.2P51654-3
GPC3
ENST00000631057.2
TSL:1
c.175+32092G>A
intron
N/AENSP00000486325.1P51654-2

Frequencies

GnomAD3 genomes
AF:
0.0108
AC:
1195
AN:
110476
Hom.:
22
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0365
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00662
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00851
Gnomad NFE
AF:
0.0000755
Gnomad OTH
AF:
0.0102
GnomAD2 exomes
AF:
0.00301
AC:
552
AN:
183118
AF XY:
0.00205
show subpopulations
Gnomad AFR exome
AF:
0.0376
Gnomad AMR exome
AF:
0.00164
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000367
Gnomad OTH exome
AF:
0.00199
GnomAD4 exome
AF:
0.00113
AC:
1235
AN:
1096481
Hom.:
9
Cov.:
30
AF XY:
0.000851
AC XY:
308
AN XY:
361857
show subpopulations
African (AFR)
AF:
0.0356
AC:
938
AN:
26375
American (AMR)
AF:
0.00205
AC:
72
AN:
35205
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19377
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30196
South Asian (SAS)
AF:
0.0000554
AC:
3
AN:
54116
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40483
Middle Eastern (MID)
AF:
0.00169
AC:
7
AN:
4134
European-Non Finnish (NFE)
AF:
0.0000952
AC:
80
AN:
840559
Other (OTH)
AF:
0.00293
AC:
135
AN:
46036
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
60
120
179
239
299
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0108
AC:
1191
AN:
110530
Hom.:
22
Cov.:
23
AF XY:
0.00882
AC XY:
289
AN XY:
32778
show subpopulations
African (AFR)
AF:
0.0363
AC:
1103
AN:
30350
American (AMR)
AF:
0.00661
AC:
68
AN:
10283
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2634
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3517
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2548
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5840
Middle Eastern (MID)
AF:
0.00469
AC:
1
AN:
213
European-Non Finnish (NFE)
AF:
0.0000755
AC:
4
AN:
52978
Other (OTH)
AF:
0.0101
AC:
15
AN:
1489
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
44
88
131
175
219
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00540
Hom.:
26
Bravo
AF:
0.0123
EpiCase
AF:
0.000218
EpiControl
AF:
0.000119

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
-
2
not provided (2)
-
-
1
GPC3-related disorder (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
Simpson-Golabi-Behmel syndrome type 1 (1)
-
-
1
Wilms tumor 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.37
CADD
Benign
9.8
DANN
Benign
0.69
PhyloP100
1.9
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61754632; hg19: chrX-133087210; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.